In the present study, we established, using a larger cohort of clinical prostate cancer samples, a correlation between elevated BIRC6 expression and advanced prostate cancer - evidence supporting a role for BIRC6 in the malignant progression of the disease. Here, BIRC6 is linked to Familial prostate cancer.